Urinary retention in female OAB after intravesical Botox injection: who is really at risk?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urinary retention in female OAB after intravesical Botox injection: who is really at risk?
Authors
Keywords
Botulinum toxin A, Botox, Overactive bladder, Residual urine volume, Urgency incontinence, Urine retention
Journal
INTERNATIONAL UROGYNECOLOGY JOURNAL
Volume 28, Issue 6, Pages 845-850
Publisher
Springer Nature
Online
2016-11-26
DOI
10.1007/s00192-016-3212-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
- (2016) Victor W. Nitti et al. JOURNAL OF UROLOGY
- Can botox improve night-time overactive bladder symptoms in women?
- (2016) Pawel Miotla et al. NEUROUROLOGY AND URODYNAMICS
- Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms
- (2016) T. A. T. Marcelissen et al. WORLD JOURNAL OF UROLOGY
- Patient preferences for treating refractory overactive bladder in the UK
- (2015) Hashim Hashim et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Predictive factors of adverse events after intravesical suburothelial onabotulinumtoxina injections for overactive bladder syndrome-A real-life practice of 290 cases in a single center
- (2015) Yuan-Hong Jiang et al. NEUROUROLOGY AND URODYNAMICS
- Women’s perspective: intra-detrusor botox versus sacral neuromodulation for overactive bladder symptoms after unsuccessful anticholinergic treatment
- (2014) Pooja Balchandra et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- Trigonal versus extratrigonal botulinum toxin-A: a systematic review and meta-analysis of efficacy and adverse events
- (2014) N. F. Davis et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- Chapter 6: Practical aspects of administration of onabotulinumtoxinA
- (2014) Eric Rovner NEUROUROLOGY AND URODYNAMICS
- Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome
- (2014) David James Osborn et al. NEUROUROLOGY AND URODYNAMICS
- Lifetime Risk of Stress Urinary Incontinence or Pelvic Organ Prolapse Surgery
- (2014) Jennifer M. Wu et al. OBSTETRICS AND GYNECOLOGY
- OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
- (2013) Christopher Chapple et al. EUROPEAN UROLOGY
- Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxina injection in patients with refractory detrusor overactivity
- (2013) Chung-Cheng Wang et al. NEUROUROLOGY AND URODYNAMICS
- Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
- (2012) E. Ann Gormley et al. JOURNAL OF UROLOGY
- OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
- (2012) Victor W. Nitti et al. JOURNAL OF UROLOGY
- Increased Risk of Large Post-Void Residual Urine and Decreased Long-Term Success Rate After Intravesical OnabotulinumtoxinA Injection for Refractory Idiopathic Detrusor Overactivity
- (2012) Chun-Hou Liao et al. JOURNAL OF UROLOGY
- Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial
- (2010) Roger Dmochowski et al. JOURNAL OF UROLOGY
- An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction
- (2009) Bernard T. Haylen et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now